Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

prasterone

A synthetic form of dehydroepiandrosterone with potential chemopreventive activity. Produced endogenously, dehydroepiandrosterone (DHEA) is an intermediate in the conversion of cholesterol to androgens and estrogens. Although the mechanisms of action of exogenously administered DHEA have not been fully illuminated, they may result in both direct and indirect physiologic effects. Direct effects include GABA-a receptor complex and NMDA receptor modulation, and enhanced pancreatic beta cell insulin secretion and antiglucocorticoid activities.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Dehydroisoandrosterone
therapeutic dehydroepiandrosterone
US brand name:Fidelin
Abbreviation:DHEA
Code name:GL701
Chemical structure:3beta-Hydroxyandrost-5-en-17-one
NSC code:9896
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search